3-溴-4-羟基苯甲醇 | 29922-56-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 3-溴-4-羟基苯甲醇
• 中文别名: 2-溴-4-羟甲基苯酚
• 英文名称: 2-bromo-4-(hydroxymethyl)phenol
• 英文别名: 2-bromo-4-hydroxymethylphenol；3-bromo-4-hydroxy-benzyl alcohol；3-Brom-4.α-dihydroxy-toluol；3-Brom-4-hydroxy-benzylalkohol；2-Brom-4-hydroxymethyl-phenol
• CAS: 29922-56-3
• 化学式: C₇H₇BrO₂
• mdl: MFCD00016869
• 分子量: 203.035
• InChiKey: HAFQFRJTRZBJJF-UHFFFAOYSA-N

物化性质

• 熔点：
  128-132℃
• 沸点：
  307.8±27.0 °C(Predicted)
• 密度：
  1.722±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1.4
• 重原子数：
  10
• 可旋转键数：
  1
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.14
• 拓扑面积：
  40.5
• 氢给体数：
  2
• 氢受体数：
  2

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 危险性防范说明：
  P261,P305+P351+P338
• 危险性描述：
  H302,H315,H319,H335
• 储存条件：
  室温且干燥环境下使用。

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
3-Bromo-4-hydroxybenzyl alcohol
Product Name:
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.
H315: Causes skin irritation
H319: Causes serious eye irritation
H335: May cause respiratory irritation
P305+P351+P338: IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses if present
and easy to do – continue rinsing

---

Section 3. Composition/information on ingredients.
Ingredient name: 3-Bromo-4-hydroxybenzyl alcohol
CAS number: 29922-56-3

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
This product should be handled only by, or under the close supervision of, those properly qualified
Handling:
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C7H7BrO2
Molecular weight: 203

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, hydrogen bromide.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  3-溴-4-羟基苯甲醇 在 吡啶 、 盐酸 、 二(三叔丁基膦)钯 、 N-甲基二环己基胺 、 5%-palladium/activated carbon 、 氢气 、 sodium carbonate 、 三乙胺 、 sodium hydroxide 作用下， 以 2-甲基四氢呋喃 、 乙醇 、 二氯甲烷 、 水 、 甲苯 、 乙腈 、 丁酮 为溶剂， 5.0~86.0 ℃ 、100.0 kPa 条件下， 反应 1.0h， 生成 弗斯特罗定
  参考文献：
  名称：

  [EN] PROCESS FOR THE PREPARATION OF 2-(3-N,N-DIISOPROPYLAMINO-1-PHENYLPROPYL)-4-HYDROXYMETHYL-PHENOL AND ITS DERIVATIVES
  [FR] PROCÉDÉ POUR LA PRÉPARATION DE 2-(3-N,N-DIISOPROPYLAMINO-1-PHÉNYLPROPYL)-4-HYDROXYMÉTHYLPHÉNOL ET DE SES DÉRIVÉS

  摘要：

  这项发明涉及一种制备2-(3-N,N-二异丙基氨基-1-苯基丙基)-4-羟甲基苯酚及其衍生物的方法，特别是相应的(R) 4-三苯甲氧基甲基衍生物，作为费索特罗定及其盐的合成中间体形式，特别用于费索特罗定富马酸盐的制备。

  公开号：

  WO2014012832A1
• 作为产物：
  描述：

  对羟基苯甲醇 在 溴 作用下， 生成 3-溴-4-羟基苯甲醇
  参考文献：
  名称：

  Applying conjoint analysis in economic evaluations: an application to menorrhagia

  摘要：

  DOI：

  10.1080/000368400322165

文献信息

• A highly efficient approach to vanillin starting from 4-cresol
  作者：Jian-An Jiang、Cheng Chen、Ying Guo、Dao-Hua Liao、Xian-Dao Pan、Ya-Fei Ji

  DOI：10.1039/c4gc00003j

  日期：——

  A highly efficient approach to the famous flavor and fragrance compound vanillin has been developed starting from 4-cresol with the attention focused on improving the sustainability of all the reactions. The approach involves a three-step sequence of the quasi-quantitative selective clean oxybromination of 4-cresol, the high-yield selective aerobic oxidation of 2-bromo-4-cresol, and the quantitative methoxylation of 3-bromo-4-hydroxybenzaldehyde with the recovery of pure methanol. Herein, the pivotal oxidation and methoxylation reactions are logically investigated and developed into two concise methodologies. As a green alternative, the approach holds significant value for the sustainable manufacturing of vanillin.

  一种从4-甲酚出发制备著名香料与香精化合物香兰素的高效方法已被开发，该方法着重于提高所有反应的可持续性。该方法包括三个步骤的序列：准定量的选择性干净氧溴化4-甲酚、高产率的选择性需氧氧化2-溴-4-甲酚，以及定量的3-溴4-羟基苯甲醛甲氧基化并回收纯甲醇。在此，关键的氧化和甲氧基化反应被逻辑上研究和开发成两种简洁的方法。作为一种绿色替代方案，该方法对于香兰素的可持续制造具有重要价值。
• Hybrid Dual Aromatase-Steroid Sulfatase Inhibitors with Exquisite Picomolar Inhibitory Activity
  作者：L. W. Lawrence Woo、Christian Bubert、Atul Purohit、Barry V. L. Potter

  DOI：10.1021/ml100273k

  日期：2011.3.10

  topical. Hormone-dependent breast cancer (HDBC) may be more effectively treated by dual inhibition of aromatase and steroid sulfatase (STS), and several dual aromatase-sulfatase inhibitors (DASIs) have been recently reported. The best compounds from two leading classes of DASI, 3 and 9, are low nanomolar inhibitors. In search of a novel class of DASI, core motifs of two leading classes were combined

  针对多种药物靶标的单一药物具有高度的局部性。通过双重抑制芳香化酶和类固醇硫酸酯酶（STS），可以更有效地治疗激素依赖性乳腺癌（HDBC），最近已经报道了几种双重芳香化酶-硫酸酯酶抑制剂（DASI）。来自两大类DASI的最佳化合物3和9是低纳摩尔抑制剂。为了寻找一类新的DASI，将两个主要类别的核心基序组合在一起以提供一系列杂化结构，其中几种化合物在JEG-3细胞的皮摩尔范围内显示出显着改善的双重抑制活性。因此，DASI 14（IC50：芳香化酶，15 pM； STS，830 pM）和15（IC50：芳香化酶，18 pM； STS，
• [EN] AROMATASE INHIBITOR<br/>[FR] INHIBITEUR D'AROMATASE
  申请人：STERIX LTD

  公开号：WO2011023989A1

  公开（公告）日：2011-03-03

  There is provided a compound of formula (I) wherein Z is selected from N and CR22, wherein R22 is H or a bond with D, wherein D is selected from a bond, C=O, and linear or branched hydrocarbon groups having a carbon chain of from 1 to 6 carbon atoms, wherein the carbon chain optionally contains an oxy group (=0), an ether (-0-) or thioether (-S-) link, wherein R1 is selected from :triazolyl, imidazolyl, pyrimidinyl radical wherein each of R2 to R6 is independently selected from -H, NO2, halo, -CN, -N[(C=O)0-1R12][(C=O)0-1R13] and -(CH2)0-1R14, or two adjacent groups of R2 to R6, together with the carbon atoms to which they are attached, form a ring, wherein at least one of R2 to R6 is -CN, wherein (i) at least one of R2 to R6 is -(CH2)0-1R14, or (ii) at least one of R2 to R6 is -N[(C=O)0-1, R12][(C=O)0-1R13], or (iii) at least two adjacent groups of R2 to R6 together with the carbon atoms to which they are attached, form a ring, or (iv) at least one of R2 to R6 is -(CH2)0-1O-R'14, wherein R12 and R13 are independently selected from H, linear or branched hydrocarbon groups having a carbon chain of from 1 to 10 carbon atoms, or together with the atoms to which they are attached, may form a mono or bicyclic ring having from 5 to14 ring members wherein R14 is selected from: aliphatic ring systems; unsubstituted or substituted monocyclic aliphatic heterocycles; unsubstituted or substituted heteroaryl radical, and unsubstituted or substituted phenyl group; the group of formula (a) wherein t is 1 or 2, wherein R'14 is a unsubstituted or substituted phenyl group, wherein each of R7 to R11 is independently selected from -H, NO2, halo, -O-(C1-C6)haloalkyl, (C1-C6)haloalkyl, (C1-C6)alkyl, -CN, -OH, -OPh, -OBn, -Ph, -OSO2NR15R16, -SO2R26, -SO2NR27NR28, -O-(C1C6)alkyl, -(C=O)0-1NR29R30 and -CO(O)0-1R31; wherein R15 and R16 are independently selected from H, alkyl, cycloalkyl, alkenyl, acyl and aryl, or combinations thereof, or together represent alkylene, wherein the or each alkyl or cycloalkyl or alkenyi optionally contain one or more hetero atoms or groups wherein each of R26 to R31 is independently selected from H, alkyl, cycloalkyl, alkenyl, acyl and aryl, or combinations thereof, or together represent alkylene, wherein the or each alkyi or cycloalky! or alkenyl optionally contain one or more hetero atoms or groups, or any pharmaceutically acceptable salts thereof.

  提供了一个式(I)的化合物，其中Z从N和CR22中选择，其中R22是H或与D形成键，其中D从键，C=O和线性或支链碳链为1至6个碳原子的烃基中选择，其中碳链可选地含有氧基(=0)，醚(-0-)或硫醚(-S-)键，其中R1从：三唑基，咪唑基，嘧啶基中选择，其中R2到R6中的每个独立地从-H，NO2，卤素，-CN，-N[(C=O)0-1R12][(C=O)0-1R13]和-(CH2)0-1R14中选择，或者R2到R6中的两个相邻基团，与它们连接的碳原子一起形成一个环，其中R2到R6中至少有一个是-CN，其中(i)R2到R6中至少有一个是-(CH2)0-1R14，或者(ii)R2到R6中至少有一个是-N[(C=O)0-1, R12][(C=O)0-1R13]，或者(iii)R2到R6中至少有两个相邻基团，与它们连接的碳原子一起形成一个环，或者(iv)R2到R6中至少有一个是-(CH2)0-1O-R'14，其中R12和R13独立地从H，线性或支链碳链为1至10个碳原子的烃基中选择，或者与它们连接的原子一起，可以形成具有5至14个环成员的单环或双环环，其中R14从中选择：脂环系统；未取代或取代的单环脂杂环；未取代或取代的杂芳基，和未取代或取代的苯基；式(a)的基团，其中t为1或2，其中R'14是未取代或取代的苯基，其中R7到R11中的每个独立地从-H，NO2，卤素，-O-(C1-C6)卤代烷基，(C1-C6)卤代烷基，(C1-C6)烷基，-CN，-OH，-OPh，-OBn，-Ph，-OSO2NR15R16，-SO2R26，-SO2NR27NR28，-O-(C1C6)烷基，-(C=O)0-1NR29R30和-CO(O)0-1R31中选择；其中R15和R16独立地从H，烷基，环烷基，烯基，酰基和芳基中选择，或者它们的组合，或者一起代表烷基，其中每个R26到R31独立地从H，烷基，环烷基，烯基，酰基和芳基中选择，或者它们的组合，或者一起代表烷基，其中每个烷基或环烷基或烯基可选地含有一个或多个杂原子或基团，或其任何药学上可接受的盐。
• A Domino Process for Benzyne Preparation: Dual Activation of <i>o</i>-(Trimethylsilyl)phenols by Nonafluorobutanesulfonyl Fluoride
  作者：Takashi Ikawa、Tsuyoshi Nishiyama、Toshifumi Nosaki、Akira Takagi、Shuji Akai

  DOI：10.1021/ol200252c

  日期：2011.4.1

  Benzynes were generated from o-(trimethylsilyl)phenols using nonafluorobutanesulfonyl fluoride (NfF) by a domino process, i.e., the nonaflation of the phenolic hydroxyl group of o-(trimethylsilyl)phenols by NfF followed by the attack of the produced fluoride ion on the trimethylsilyl group. The generated benzyne immediately underwent various reactions to give polysubstituted benzenes.

  苯并呋喃是使用多氟米诺法从邻氟（三甲基甲硅烷基）苯酚中生成邻苯三甲酰苯磺酰氟（NfF）生成的，即，邻氟苯甲酰（NfF）非邻氨基化（邻氨基苯甲酸酯基）苯酚羟基，然后将生成的氟离子攻击三甲基甲硅烷基。产生的苯并炔立即经历各种反应，得到多取代的苯。
• Enantioselective total synthesis and absolute configuration of the alleged structure of crassinervic acid
  作者：Jyotsna N. Chakor、Lucio Merlini、Sabrina Dallavalle

  DOI：10.1016/j.tet.2011.06.015

  日期：2011.8

  An enantioselective synthesis of the structure reported for the natural antifungal compound, (−)-crassinervic acid (1), has been achieved starting from geraniol and p-hydroxybenzoic acid. The key chirality-inducing step is a Sharpless asymmetric epoxidation of an allylic alcohol, on the basis of which the S configuration can be assigned to the (−) natural enantiomer. The discrepancies between the spectroscopic

  从香叶醇和对羟基苯甲酸开始，已经实现了报道的天然抗真菌化合物（-）-crassinervic acid（1）的结构的对映选择性合成。关键的手性诱导步骤是烯丙醇的Sharpless不对称环氧化，在此基础上，S构型可分配给（-）天然对映体。合成的和天然的尼古丁酸的光谱数据之间的差异使人们对分配给天然化合物的结构产生了怀疑。讨论了可能的修订结构。